NanoViricides, Inc. finalizes a clinical trial protocol for its MPox drug NV-387 to combat orthopoxviruses, while Lorati Co., Ltd. introduces Lorati Nano-Emulsion for stroke recovery, showcasing innovative and effective solutions in the medical field.
